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ABSTRACT
Analysis of the human protein-tyrosine phosphatase
(PTP) PTPRJ mRNA detected three in-frame AUGs at
the 5’-end (starting at nt +14, +191 and +356) with no
intervening stop codons. This tandem AUG arrange-
ment is conserved between humans and the mouse
and is unique among the genes of the classical PTPs.
Until now it was assumed that the principal open
reading frame (ORF) starts at AUG356. Our experi-
ments showed that: (i) translation of the mRNA
synthesized under the PTPRJ promoter starts pre-
dominantly at AUG191, leading to the generation of
a 55 amino acid sequence preceding the signal pep-
tide; (ii) the longer form is being likewise correctly
processed into mature PTPRJ; (iii) the translation of
the region between AUG191 and AUG356 inhibits the
overall expression, a feature which depends on the
sequence of the encoded peptide. Specifically, a
sequence of 13 amino acids containing multiple argi-
nine residues (RRTGWRRRRRRRR) confers the inhi-
bition. In the absence of uORF these previously
unrecognized characteristics of the 5’-end of the
mRNA present a novel mechanism to suppress,
and potentially to regulate translation.
INTRODUCTION
It has been noted that a wide variety of proteins, including
some protein kinases, growth factors, oncogenes, recep-
tors and transcription factors are expressed from messen-
gers, which are poorly translated (1). The mRNAs of these
proteins are characterized by a long 50 leader (50UTR)
with high GC content, potentially strong secondary struc-
ture and the presence of short upstream open reading
frames (uORFs). Recent genome wide analyses have
revealed that uAUGs and uORFs are quite common
(2,3). Generally the translation of these mRNAs follows
the standard route for eukaryotes. The 43S scanning com-
plex, composed of the 40S ribosomal subunit, Met-tRNAi
and translation initiation factors, is attached to the m
7G
cap at the 50-end of the mRNA. Unwinding the regions
with secondary structure, the scanning proceeds towards
the 30-end, and when an AUG triplet in a favorable con-
text is encountered, the 60S ribosomal subunit is recruited
and translation initiates. The presence of an uORF
impairs the translation of the principal reading frame as
the ribosomes need to reinitiate at the downstream AUG.
Alternatively, the sequence environment of the upstream
AUG (uAUG) may diverge from the one which is optimal
for recognition by the scanning complex [A/G]CCaugG
(4). In this case, some of the 40S subunits will start trans-
lation at the uAUG, while others will continue scanning
(‘leaky scanning’).
It is generally assumed that the role of the uORF is to
secure low levels of expression of proteins which are harm-
ful to the cell when abundant (5–7). In addition, regula-
tory functions of uORFs have also been identiﬁed, for
example for the CAAT enhancer binding proteins alpha
and beta and for the SCL transcription factor (8,9).
The receptor-like protein-tyrosine phosphatase J
(PTPRJ, also designated DEP-1, CD148), a candidate
tumor suppressor protein with potent anti-proliferative
and anti-migratory activity, is diﬀerently expressed in dif-
ferent cell types and at diﬀerent cell densities (10,11). By
dephosphorylating yet only partially characterized cellular
substrates it can interfere with signal transduction down-
stream of several growth factor receptors, and exerts anti-
transforming activity in cancer cell lines of diﬀerent origin
(12–19). Therefore regulation of PTPRJ expression may
represent an important level of controlling cellular tyro-
sine phosphorylation, and deregulation of expression may
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basic mechanisms of PTPRJ expression regulation have
not been explored until now.
Some of the structural features of the mRNAs discussed
above are shared by the mRNA of PTPRJ, in particular a
long, GC rich 50 leader (GC 82%). However, this region
contains three AUGs, all of which are in the reading frame
of the main protein, with no intervening stop codons.
Experiments addressing the mechanisms of PTPRJ
expression regulation showed that translation of the
mRNA starts predominantly at AUG191, 55 codons
upstream of the AUG356, the start of the signal peptide.
We discovered properties of the 50 leader, which have
hitherto not been described in other genes. In the
tandem arrangement of the in-frame AUGs, the codons
between them are poorly translated, resulting in lower
expression. These results uncover a previously unrecog-
nized mechanism of suppressing and potentially regulating
translation, which may be relevant not only to PTPRJ.
MATERIALS AND METHODS
Fireflyluciferase reporter constructs
Reporter constructs with ATGLuc present. ‘In-frame’ (InF)
and ‘Out-of-frame’ (OutF) constructs. The genomic
region of human PTPRJ containing the putative promoter
and the 50 leader was ampliﬁed from BAC DNA (details in
Supplementary Data and Supplementary Figure 1). The
fragment (1762 bp, GenBank EF219146) was cloned into
the NheI and BglII sites of pGL3-Basic Vector (Promega,
Mannheim, Germany), which lacks eukaryotic promoter
or enhancer. The construct p1.7_InF(pGL3) contained
nucleotides from  1419 to +343 of PTPRJ (+1 is the
transcription start site, NM_002843). The arrangement of
the ATGs in this clone was the same as in PTPRJ—all
three ATGs (ATG14, ATG191 and ATGLuc) were in one
reading frame. Clone pNar_InF(pGL3) contained
sequences  323 to +343. The pNar(17)_OutF clone was
the same as pNar_InF(pGL3) but with additional 17
nucleotides in the region between +343 and ATGLuc.
The additional nucleotides changed the reading frame.
The clone with deleted 30 region – pNar-Nar_InF(pGL3),
contained sequences from  323 to +82. For details on all
cloning steps, see Supplementary Data.
Constructs with PTPRJ fused to firefly luciferase. The
construct pNar_Luc_Fused(pGL3) expressed the ﬁreﬂy
luciferase fused to the ﬁrst ﬁve N-end amino acids of
PTPRJ (starting with AUG356). The construct was pre-
pared by PCR and contained PTPRJ sequences from
 323 to +370, followed by the ﬁreﬂy luciferase sequences
coding amino acids 2–550. All mutations of the ATGs
were performed by PCR and the respective clones were
sequenced. ATG14 was mutated to TTG (Leu); ATG191
to AGG (Arg), and ATG356 to ATT (Ile).
Constructs with PTPRJ 50 leader and luciferase trans-
cribed from the CMV promoter. The constructs in
pcDNA3.1(+) (Invitrogen, Karlsruhe, Germany)
contained PTPRJ sequences from +171 to +370
followed by ﬁreﬂy luciferase codons from 2 to 550 and
the stop codon. In these constructs, designated as
(191–356)(Luc)(pcDNA3), the ﬁreﬂy luciferase was trans-
cribed under the strong CMV promoter and translated
from the AUG191 and AUG356 of PTPRJ.
Constructs with frame-shift mutations and with optimized
codons. Frame-shift mutations in the region between
+191 and +356 (without introducing a stop codon)
were performed by PCR. We inserted one A (after
+200) in the codon 4 (AUG191 is codon 1) or deleted
one C (+340) in the 5th codon preceding AUG356. The
distance between the frame shifts was 139nt, and, when
both frame-shift mutations are present in one template,
47 codons were altered. The optimization of codons
for human translation and synthesis of the fragment
was done by GENEART AG (Regensburg, Germany)
by assembling synthetic oligonucleotides and PCR pro-
ducts, and was veriﬁed by DNA sequencing. For further
details and sequences of the wild type region ATG191–
ATG236, the double frame-shift, and the optimized
codons, see the Supplementary Data and Supplementary
Figure 4.
Constructs with deleted codons in the 30-end of the region
AUG191–AUG356. Constructs with deleted codons (vector
pcDNA3.1) were created by site-directed mutagenesis.
They contained sequences from +171 to +270 (codons
1–26), followed by four codons of the signal peptide and
codons 2–550 of the ﬁreﬂy luciferase. In these clones,
designated as (191-)(Luc)(pcDNA3), the transcription
is driven by the CMV promoter, and the translation by
AUG191 (AUG356 is modiﬁed to CAU, encoding His).
Two double frame-shift mutants were also constructed—
one altering the sequence of codons 4 through 13, and the
other altering the sequence of codons 4 through 26 (for the
sequence of the wild type and the frame-shifted codons,
see Supplementary Figure 5).
PTPPRJ cDNA clones
The human PTPRJ cDNA has been described previously
(10); accession U10886. The cDNA was inserted in
the EcoRI site of the expression vector pcDNA3
(Invitrogen, Kalsruhe, Germany) and contained at the
C-end a HA tag (3 ). Mutations of the ATGs and the
double frame-shift mutation were prepared by PCR and
veriﬁed by sequencing.
Cell culture, transfection and antibodies
HEK293 and HeLa cells cells were maintained in DMEM/
F12 1:1 medium, and HCT116 cells in McCoy’s medium,
all supplemented with 10% FBS. All transfections were
done with PEI (polyethylenimine, Aldrich, Cat. No.
40872-7, transfection protocol in Supplementary Data).
Cells were lysed in buﬀer with 1% Triton X100, 20mM
HEPES (pH 7.4), 150mM NaCl, 2mM EDTA, 2mM
EGTA, 5% glycerol, supplemented with protease inhi-
bitors. Immunoprecipitation was performed with goat
anti-ﬁreﬂy luciferase polyclonal antibody from
Chemicon (Cat. No. AB3256, Millipore, Schwalbach,
4444 Nucleic Acids Research, 2008, Vol. 36, No. 13Germany) cross-linked to Protein G Sepharose beads with
dimethylpimelimidate (DMP) according to standard pro-
cedures. To determine the synthesis of HA-tagged PTPRJ,
HEK293 cells growing in 6-well plates were transfected
with constructs in pcDNA3, together with a plasmid
encoding EYFP-tagged SHP1 (20) for control of transfec-
tion eﬃciency. The anti-HA monoclonal antibody was
from Cell Signaling Technology (cat. No 2362, Frankfurt,
Germany) and the anti-SHP1 antibody was from Santa
Cruz (sc-287, Heidelberg, Germany).
Determination of dualfirefly—Renilla luciferase activity
To determine the expression of the ﬁreﬂy luciferase,
HEK293 cells were grown in 96-well plates (ﬂat bottom,
clear, Greiner Bio-One, Frickenhausen, Germany, cat. No
655098) coated with 10mg/ml poly-L-lysine (Sigma-
Aldrich, Deisenhofen, Germany). Transfection (0.2mg
DNA per well) was with ﬁreﬂy luciferase constructs
(or vector pGL3-Basic alone). To determine the eﬃciency
of transfection and to normalize values plasmid DNA
coding for Renilla luciferase was added (pRL-TK in
ratio 1:16 with constructs in pGL3 or pRL-CMV in
ratio 1:40 with constructs in pcDNA3.1. Both Renilla
expressing plasmids are from Promega, Mannheim,
Germany). After 24h the cells were washed with PBS,
lysed with Passive Lysis Buﬀer (Promega, Mannheim,
Germany) and the dual-luciferase activity was measured
(21). The expression of constructs was measured in at least
three independent experiments (8–12 wells in each experi-
ment). The values were normalized as a ratio of ﬁreﬂy to
Renilla luciferase activity. Where indicated the fold
increase of construct activity over the activity of the pro-
moter-less pGL3 is presented.
Determination of RNA levels by Northern hybridization
and real-time RT–PCR
HEK293 cells were transfected with constructs with
PTPRJ 50 leader and ﬁreﬂy luciferase transcribed from
the CMV promoter (vector pcDNA3.1) together with
pRL-CMV DNA (Promega, Mannheim, Germany) for
normalization. Total RNA was isolated with the
RNeasy Mini kit (Qiagen, Hilden, Germany), fractionated
on 1% agarose-formaldehyde gels, blotted on Hybond N
membranes (GE Healthcare, Freiburg, Germany) and
hybridized to DIG-labelled PCR fragment in 20% SDS,
0.25M sodium phosphate, 50% formamide buﬀer at 428
(22). For labelling details, see Supplementary Data.
Detection of the hybrids on the blots was with anti-DIG
POD Fab fragments (Roche, Penzberg, Germany) accord-
ing to the manufacturers instructions.
For real-time RT–PCR, the RNA preparations were
additionally treated with Ampliﬁcation Grade DNase I
(Invitrogen, Karlsruhe, Germany) according to the proto-
col of the manufacturer. The inactivation of the DNase I
was checked on supercoiled plasmid DNA. cDNA was
prepared by the SuperScript First-Strand Synthesis
System for RT–PCR with oligo(dT)12–18 (Invitrogen,
Karlsruhe, Germany). Ampliﬁcation of the target
cDNA was performed with the QuantiTect SYBR Green
PCR Kit (Qiagen, Hilden, Germany) using primers
speciﬁc for ﬁreﬂy luciferase cDNA and Renilla luciferase
cDNA. The level of residual contamination with plasmid
template DNA was checked with primers speciﬁc for the
beta-lactamase resistance gene (for primer sequences, see
Supplementary Data).
RESULTS
The structural features of the first exon ofPTPRJ
arehighly conserved
Examination of the 50-end of PTPRJ mRNA
(NM_002843) showed the presence of three AUGs
which are in the reading frame of the main protein.
Comparison of the ﬁrst exon of the human PTPRJ and
its mouse homolog (NM_008982) revealed that they share
a common pattern of organization and several remarkable
similarities (Figure 1A and B). First, the length of both
exons is almost the same (451nt human, mouse 442nt);
they code for the 50 leader of the mRNA, and for 32 amino
acids of the predicted signal peptide. Second, both exons
contain three tandem AUGs in one reading frame, with no
intervening stop codons. The relative position and the
context of the AUGs are also conserved (Table 1).
Third, in case translation starts at AUG14 (+14 to
+16), or at AUG191 (+191 to +193), the conservation
of the amino acid sequence is also high (77% identity,
Figure 1C). The high degree of conservation in the
PTPRJ 50 leader, notably the conservation of the position
of AUGs, their context and the encoded amino acids sug-
gested that this arrangement might be of functional
importance (for conservation at nucleotide sequence
level, see Supplementary Figure 2).
Translationof the mRNAsynthesized from thePTPRJ
promoter maystart atAUG356as well as at AUG191
We cloned the genomic region of the human PTPRJ (1762
bp), spanning the transcription start site into the ﬁreﬂy
luciferase reporter vector pGL3 (see Materials and
Methods section). The reporter activity analysis of several
50 deletion constructs showed that the PTPRJ core pro-
moter is located within about 300 nucleotides upstream of
the transcription start (Supplementary Figure 3).
We went on to test the functional signiﬁcance of the
above described conserved AUG arrangement. First we
tested the possibility of translation starting upstream of
AUG356 (+356 to +358), the codon, which in the public
database is marked as the translation start. For this we
compared the activity of various constructs with diﬀerent
arrangement of ATG14, ATG191 and ATGLuc (the ATG of
the ﬁreﬂy luciferase). The results showed invariably that
the reporter activity was strongly reduced when the
upstream AUGs (AUG14 and AUG191) were not in-frame
with AUGLuc (Figure 2A). This demonstrated that initia-
tion of translation takes place in the 50 leader, at AUG191
(or at AUG14). This translation then proceeds not in the
reading frame of the luciferase, thus preventing its expres-
sion. The residual reporter activity is presumably due to
leaky scanning directed towards the ATGLuc, as both
AUG14 and AUG191 are not in a perfect context (Table 1).
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ity of AUG14 and AUG191 to initiate translation. First, we
analyzed the length of the ﬁreﬂy luciferase synthesized by
the reporter constructs. The use of AUG14, or AUG191 as
start codons would give rise to longer translation products
than translation starting at the AUGLuc. HEK293 cells
were transfected with diﬀerent constructs, lysed after
24h, luciferase was immunoprecipitated and analyzed by
western blotting. As shown in Figure 2B, two luciferase
proteins were synthesized when the AUGs in the reporter
were in-frame. The sizes of the luciferase bands corre-
sponded to one product synthesized from AUGLuc
(63kDa), and another synthesized from AUG191
(69kDa). This directly indicates that AUG191 initiates
translation and that scanning is leaky. If AUG191 was
not in tandem with AUGLuc only the synthesis of ﬁreﬂy
luciferase with a size of 63kDa was supported. AUG14
appeared to be largely inactive in these constructs, since
a protein product of 76kDa, corresponding to translation
starting at AUG14 could not be detected.
Comparison of the amounts of protein with low and
higher molecular mass, shows prevalence of the 63kDa
products (starting presumably at ATGLuc). This is in dis-
crepancy with results presented on Figure 2A, which indi-
cated robust translation starting upstream of ATGLuc.W e
considered that low abundance of the form with higher
molecular mass might be caused by diﬀerential immuno-
precipitation and/or by high susceptibility to protease
degradation of the protruding N-tail of the extended pro-
tein. This seemed to be indeed the case, as further analysis
of luciferase translation products directly in cell lysates
revealed (Figure 7C).
To estimate the relative ability of each AUG codon in
the PTPRJ mRNA to sustain translation, we designed a
fusion construct, containing all three 50-end ATGs. This
construct contained (from 50 to 30) the PTPRJ core pro-
moter ( 323 to  1), the 50 leader (+1 to +355), and the
sequence coding for the ﬁrst ﬁve amino acids of the signal
peptide (+356 to +370). This sequence was fused to the
sequence of the ﬁreﬂy luciferase (codons 2–550) (see
Materials and Methods section). Mutations were intro-
duced to disrupt two AUGs at a time, leaving one AUG
intact, and the constructs were subjected to expression
analysis. As shown in Figure 3, translation can start at
Table 1. Context of the AUG codons
Human PTPRJ, codon Mouse PTPRJ, codon Sequence
AUG14 AUG11 AGCCGC AUGA
AUG191 AUG191 GCTGCC AUGT
AUG356 AUG347 CGGGGC AUGA
Other Source Sequence
Luciferase, pGL3, ATG88 Accession U47295 GCCACC AUGG
Consensus (4) GCCRCC AUGG
R is A or G
NarI NotI RsrII NgoMIV
ATG14
ATG11 ATG191 ATG347
ATG191
ORF-3 ORF-2 ORF-1
ORF-3 ORF-2 ORF-1
ATG356
Human
PTPRJ 100 300 400
100 300 400
NarI NotI RsrII
Mouse
Ptprj
A
B
C
Human    1    MTRGGGSGSSRG ---SRDRVAARWGWAPLAPPREAPARSGTRPPRGSRARLRRVAAAAAAAA    59  
     MTRGGG GSSRG  SR+  A R GWAPLAPPREAPA    RP R  RARLRRVAAAAAAA  
Mouse    1   MTRGGGRGSSRGRGSRELGATRGGWAPLAP       PREAPASLRPRPLRARRARLRRVAAAAAAA  - 60  
 
Human   60   MSPGKPGAGGAGTRRTGWRRRRRRRRQEAATTVPGLGRTAGPDSRVRGTFQGARG  114
   MSPGKPGAGGAGTRRTGWRRRRRRRR E  T  PG G TAG   RV GTFQGA+G  
Mouse   61 MSPGKPGAGGAGTRRTGWRRRRRRRRLETETRAPGFGHTAG---RVPGTFQGAQG  112
 
Human   115 MKPAAREARLPPRSPGLRWALPLLLLLLRLGQ 146 
   MKPAARE R PPRSPGLRWAL  LLLLLR GQ 
Mouse  113 MKPAARETRTPPRSPGLRWALLPLLLLLRQGQ 144 
  
Figure 1. Pattern of organization of the ﬁrst exon of the PTPRJ gene (A) in humans (NM_002843) and (B) in the mouse (NM_008982). The open
reading frames are indicated. Note that ATG14 (ATG11), ATG191 (ATG191) and ATG356 (ATG347) are in-frame with no intervening stop codons,
resulting in the same amino-acid sequence downstream of ATG356 (ATG347) when translation starts at any of them. (C) Conservation of the amino
acid sequences; from top to bottom—the amino acid sequences starting from AUG14 (AUG11), from AUG191 (ATG191), and the 32 amino acids of
the predicted signal peptide, starting from AUG356 (AUG347). Identical residues are in blue, ‘+’ represents conservative change.
4446 Nucleic Acids Research, 2008, Vol. 36, No. 13any of the AUG codons, albeit with diﬀerent eﬃciency.
Translation from AUG14 was the weakest, apparently due
to its poor sequence context (Table 1), and the short dis-
tance from the m
7G cap. The potential of AUG191 or
AUG356 to drive expression of reporter luciferase seems
approximately equal. Our further results showed that
translation starting at AUG191 is attenuated. The lack of
marked diﬀerence in expression starting from AUG191 or
AUG356, implies that AUG356 is in a weaker sequence
context; more ribosomes start at AUG191, but the overall
translation is not higher.
Translation starting atAUG191 results inacorrectly
processed protein
PTPRJ is a receptor-like protein-tyrosine phosphatase
(mature protein 1302 amino acids, calculated molecular
mass 150kDa). It contains a single intracellular catalytic
domain, a single transmembrane domain, and a number of
ﬁbronectin type III repeats in its extracellular domain. An
N-end signal peptide of 35 amino acids has been predicted
(10). The mature PTPRJ is heavily glycosylated, and
migrates as a 180–200kDa protein.
We investigated the possibility of PTPRJ synthesis from
the diﬀerent AUGs in the 50 leader, employing HA-tagged
PTPRJ cDNA constructs in pcDNA3. The ATGs in the
cDNA were point mutated, leaving either AUG191 or
AUG356 intact. The results again showed (Figure 4A)
that both AUG191 and AUG356 have the capacity to sup-
port translation. The mobility of PTPRJ synthesized from
AUG191 or from AUG356 is the same, showing a similar
degree of glycosylation. The protein bands are fairly
broad, and bands of lesser size are also detectable, reﬂect-
ing the diﬀerent extent of glycosylation of protein mole-
cules present in the cell. Apparently the presence at
synthesis of additional 55 amino acids at the N-end does
not prevent correct processing of PTPRJ, which involves
binding of the signal peptide to the recognition particle,
the subsequent correct translocation into the ER lumen,
cleavage of the signal peptide, and glycosylation. It was
of interest to know whether the speciﬁc sequence of
the additional amino acids at the N-end of PTPRJ may
play a role in the process of signal recognition. To test this
we designed an expression construct with two frame-shift
mutations (plus and minus) in the region between AUG191
and AUG356. These combined mutations change the
amino-acid sequence upstream of AUG356, but leave
the reading frame for the signal peptide and the mature
PTPRJ protein intact. Judging from mobility (Figure 4B),
processing and protein glycosylation of PTPRJ were not
severely aﬀected by this manipulation. We conclude that
the additional amino acids preceding the signal peptide are
compatible with correct processing,
Translationstarts predominantly atAUG191
The results on the expression of PTPRJ from the cDNA
constructs as well as on the expression of the luciferase
reporters showed that translation could start at AUG191,
as well as at AUG356. Further experiments were per-
formed to estimate what fraction of scanning complexes
would start translation from AUG191. For this we again
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Figure 2. In PTPRJ promoter/luciferase reporter constructs translation
can start at AUG191 as well as at AUG356.( A) Inhibition of reporter
activity when AUG191 and AUGLuc are not in-frame. Fireﬂy luciferase
reporter constructs were transiently transfected into HEK293 cells, and
activity was measured (details in Materials and Methods section).
Relative luciferase activity represents the ratio of ﬁreﬂy luciferase and
Renilla luciferase activity (pRL-TK) normalized to empty vector con-
trols (pGL3-Basic). The frame shift is indicated by a shifted ﬁreﬂy
luciferase gene. (B) Synthesis of extended ﬁreﬂy luciferase from various
constructs. HEK293 cells were transfected with the indicated con-
structs. Cell extracts were subjected to immunoprecipitation with
anti-ﬁreﬂy luciferase antibodies (covalently coupled to beads), and sub-
sequently immunoblotted with anti-ﬁreﬂy luciferase antibodies. Size
marker, and the relative positions of the expected translation products
are indicated.
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Figure 3. Contribution of the diﬀerent AUGs to the activity of reporter
constructs containing the PTPRJ promoter and the 50 leader, fused to
the ﬁreﬂy luciferase. Activity of the fusion constructs (vector pGL3,
core PTPRJ promoter) with point mutations in the ATGs (indicated
by asterisks). Relative luciferase activity represents the ratio of ﬁreﬂy
luciferase and Renilla luciferase activity (pRL-TK) normalized to empty
vector controls (pGL3-Basic).
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insertion or one deletion) positioned in the region between
AUG191 and AUG356. These frame-shift mutation deviate
the translation starting at AUG191 into a reading frame,
diﬀerent from that of the luciferase. In this case, it is
reasonable to assume that luciferase can be produced
only by initiation of translation at AUG356 (resulting
from leaky scanning at AUG191). Both frame-shift muta-
tions caused a severe reduction of reporter activity, indi-
cating that more than two-third of the scanning complexes
start translation at AUG191 (Figure 5). The prevalence of
translation from AUG191 was conﬁrmed by analyzing the
translation products by immunoblotting of the lysates of
transfected cells (see section ‘Translation of the codons
between AUG191 and AUG356 slows down expression’).
Attenuation ofPTPRJ expression by asequence
downstream ofAUG191
The highly conserved features of the 50-end of the PTPRJ
mRNA, and the start of translation from the AUG191
suggest a functional signiﬁcance of this region of the mes-
senger. The 50-end of the mRNA is very GC-rich (82%)
and highly structured. The predicted secondary structure
of nucleotides +1 to +358 with overall free energy
dG= 186.70 (23) is presented in Supplementary
Figure 6. To investigate the role of this region,
we prepared a deletion mutant missing nucleotides from
+83 to +343, eliminating part of the structured 50 leader
as well as the conserved ATG191. The results showed that
the reporter activity of this construct is increased
(Figure 6). We considered the possibility that the eﬀect
of the +83 to +343 deletion is solely due to loss of sec-
ondary structure, making scanning easier. To test this,
ATG191 was eliminated by point mutation (to AGG,
coding Arg). As supposed the single nucleotide change
did not aﬀect signiﬁcantly the RNA secondary structure
(dG= 183.10).
Unexpectedly, however, this mutation increased repor-
ter activity as it was the case with the deletion (Figure 6).
To explain these results we made the following assump-
tion, which we tested further. Translation of the codons
that follow AUG191 may not be eﬃcient, presumably
leading to pausing of translating ribosomes and lowering
the total expression. Thereby scanning through this
region may be more favorable than translation itself.
In case the translation from AUG191 is abolished,
A
anti-HA
anti-SHP1
vector control
all ATGs mutated
only ATG 191  active
only ATG 356  active
all ATGs active
B
anti-HA
anti-SHP1
vector control
ATG 191, 356  active
ATG 191, 356  active, 
     aa sequence altered
only ATG 191  active,
     aa sequence altered
PTPRJ
PTPRJ
Figure 4. Expression of HA tagged PTPRJ with diﬀerent 50 leader
sequences driven by the CMV promoter in pcDNA3. HEK293 cells
were transiently transfected with the indicated constructs expressing
PTPRJ with HA-epitope at the C-terminus. To normalize for transfec-
tion eﬃciency, co-transfection with hSHP-1 expression plasmid was
performed (SHP-1 is not expressed endogenously in HEK293 cells).
Cell extracts were subjected to SDS–PAGE and immunoblotting
using anti-HA antibodies and anti-hSHP-1 antibodies. (A) cDNA con-
structs with diﬀerentially inactivated ATGs were compared, as indi-
cated. All lanes were on the same blot with identical exposure and
image processing, but rearranged for better clarity. (B) The role of
the amino-acid sequence downstream of ATG191 was tested by altering
the sequence between ATG191 and ATG356.
Relative luciferase activity
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−323
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−323
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−323
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ATG356 ATG191 ATG14
+
−
0 5 10 15 20 25
Figure 5. Preferred initiation of translation at ATG191. Wild-type con-
struct, construct with plus frame shift mutation (insertion of a single
nucleotide at codone 4; AUG191is codone 1), and a construct with
minus frame-shift mutation (deletion of a single nucleotide in codon
51) were transiently transfected and luciferase activity was determined
(vector pGL3, core PTPRJ promoter). Relative luciferase activity
represents the ratio of ﬁreﬂy luciferase and Renilla luciferase activity
(pRL-TK) normalized to empty vector controls (pGL3-Basic).
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Figure 6. Inhibition of expression by translation initiating at AUG191.
Fireﬂy luciferase reporters (vector pGL3, core PTPRJ promoter) with
non-mutated sequence, with deletion downstream of +84 and with
point mutated AUG191 (indicated by an asterisk) were transiently trans-
fected and activity was compared. Relative luciferase activity represents
the ratio of ﬁreﬂy luciferase and Renilla luciferase activity (pRL-TK)
normalized to empty vector controls (pGL3-Basic).
4448 Nucleic Acids Research, 2008, Vol. 36, No. 13the scanning complexes continue unrestrained towards the
downstream AUG.
Translation of thecodonsbetween AUG191 andAUG356
slows down expression
To investigate further the causes for the ineﬃcient transla-
tion downstream of AUG191, and to exclude that the
eﬀects are promoter-speciﬁc, we generated several repor-
ters in the pcDNA3 vector. The constructs downstream of
the CMV promoter contained PTPRJ sequences from
+171 to +370, which encode ATG191, the downstream
region (wild type or modiﬁed), ATG356, plus the codons
of the next 4 amino acids of PTPRJ, fused to the codons of
the ﬁreﬂy luciferase for amino acids 2–550 (see Materials
and Methods section). In these reporters the luciferase
mRNA is transcribed from the strong cytomegalovirus
promoter, however, translation is dependent on the
tandem AUG191 and AUG356 (and the region between
them). We compared the activity of several constructs:
the wild-type construct, a construct with one frame-shift
mutation, a construct in which the sequence of 47 amino
acids was altered by introducing two point mutations, of
which the ﬁrst one altered, and the second one restored the
reading frame, and a construct in which these 47 amino
acids were deleted (Supplementary Figure 4). As expected,
the activity of the construct with one frame-shift mutation
was low, again demonstrating that translation initia-
tion starts predominantly at AUG191. As shown in
Figure 7A, the reporter activity increased 2–3-fold when
the amino acid sequence of the region between AUG191
and AUG356 was altered or deleted. This indicated that
translation of the codons following AUG191 reduces the
overall expression of the reporter. The similar level of
expression of these two constructs (3 and 5) shows addi-
tionally that the elimination of the region with potentially
strong secondary structure has no great eﬀect on
translation.
The luciferase fusion constructs under the CMV
promoter were also employed to test the length of the
produced luciferase proteins by immunoblotting.
Transient transfection with CMV promoter-driven con-
structs produced enough reporter luciferase to be detected
by immunoblotting directly in the cell lysates (as opposed
to products driven by the core PTPRJ promoter, see
section ‘The region between AUG191 and AUG356 is diﬃ-
cult to translate’). The results presented in Figure 7C show
that the protein with higher molecular mass, correspond-
ing to translation from AUG191 is preferentially produced.
However, after immunoprecipitation the ratio of products
is changed, disfavoring the form with higher molecular
mass. Presumably either immunoprecipitation of this
form is ineﬃcient, or during immunoprecipitation degra-
dation of the additional amino acids takes place (see also
Figure 2B).
We also checked the levels of the construct mRNAs in
the cell. As detected by Northern blotting, mRNA levels
were not aﬀected by introduction of the two point frame-
shift mutations (Figure 7D). Consistent with these data,
real-time RT-PCR revealed no signiﬁcant changes of the
mRNA levels (Mean Ct ﬁreﬂy luciferase—25.1, and 25.2,
control Renilla luciferase—26.3, and 26.4 for transfection
with the wild type and the double frame-shift mutant,
respectively). Thus, the increase in activity by altering
the amino-acid sequence can be attributed solely to
changes in translation eﬃciency, and not to accompanying
changes in mRNA synthesis or stability.
One possibility for the increase in reporter activity
would be the presence of rare codons in the reading
frame, which were eliminated by the frame-shift.
Examples of translation inhibition by the occurrence of
rare codons have been reported for viral genes, expressed
in mammalian cells (24,25). Inspection of the PTPRJ
sequence from +191 to +356 showed a marked codon
bias (see Supplementary Figure 4). Out of 55 codons, 14
codons are rare (http://www.kazusa.or.jp/codon/). To test
the possible relevance of rare codons for ineﬃcient trans-
lation, we used a reporter with unchanged amino acids,
but the nucleotides between ATG191 and ATG356 were
replaced with synthetic DNA encoding the same amino
acids but with codons optimized for human expression
(see Materials and Methods section, and Supplementary
Figure 4). At the same time the overall secondary structure
of the region was left largely unchanged (for the 1–284nt
of the mRNA transcribed from the pcDNA3 constructs
dG= 112.83 for the wild type and dG= 104.01 for the
mRNA with optimized codons). The results showed, how-
ever, that ‘optimizing’ the codons by replacing the rare
codons leads only to modest increase in reporter activity
(note the similarity in reporter expression of constructs
1 and 4, Figure 7A).
Another possible reason for ineﬃcient translation could
be the properties of the nascent peptide itself. The activity
of the reporter construct encoding an altered sequence
of a stretch of 47 amino acids was clearly elevated
(compare activity of constructs 1 and 3, Figure 7A).
Deletion of these amino acids also resulted in enhanced
luciferase expression (construct 5, Figure 7A). It was of
importance to know which region of the nascent 55
amino-acid peptide would contribute speciﬁcally to
the translation attenuation. To narrow this region, we
prepared a construct encoding only the 26 N-terminal
amino acids of the presumably inhibitory peptide
(Supplementary Figure 5). This construct showed low
luciferase reporter activity similar to that of the construct
containing the entire 55 amino-acid sequence (Figure 7B).
This indicated that the down-modulation is a property of
the N-terminal part of the sequence encoded downstream
of AUG191.
To deﬁne more precisely the amino-acid sequence
responsible for translation attenuation we changed the
sequence of 10 amino acids, starting with codon 4
and preceding the arginine stretch. This modiﬁcation did
not lead to signiﬁcant increase in luciferase expression
(Figure 7B and Supplementary Figure 5). However,
changing the codons from 4 through 26, again by introdu-
cing two frame-shift mutations (plus and minus) resulted
in an increase of reporter activity as it was observed with
the altered full-length 55 amino-acid sequence (Figure 7B,
construct 4 and Figure 7B, construct 3).
These results indicate that translation attenuation is
caused primarily by only 13 amino acids, which include
Nucleic Acids Research, 2008, Vol. 36, No. 13 4449a homopolymer stretch of eight arginines, encoded by
codons 19–26.
Taken together, the use of AUG191 results in ineﬃcient
translation of the PTPRJ mRNA. The impairment is
caused presumably by poorly translatable codons between
AUG191andAUG356,andmorespeciﬁcallybycodons14–26.
Cell specific and cell-density dependentdifferences in
expression driven by the tandemAUGs arenot due
to differences in translation attenuation
The existence of a poorly translated region at the 50-end of
mRNA, which can diminish expression, provides a possi-
bility for translation control. To test for possible
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Figure 7. Activity of reporter ﬁreﬂy luciferase constructs driven by the CMV promoter. (A)5 0 truncated sequence of the PTPRJ 50 leader containing
ATG191 and ATG356 was fused to the ﬁreﬂy luciferase (CMV promoter from vector pcDNA3.1). In the region between ATG191 (codon 1) and
ATG356 (codon 56) (from top to bottom): 1, the nucleotide and the encoded amino-acid sequence was left unchanged (wild type); 2, single nucleotide
at codon 51 was deleted ( ); 3, the amino acid sequence was altered by the indicated frame-shift mutations caused by inserting a single nucleotide at
codon 4, and deleting a single nucleotide at codon 51. Note that the combined frame-shift mutations alter the amino-acid sequence of the translation
product between the mutations, but the reading frame of the luciferase is maintained and luciferase can be produced. 4, A synthetic nucleotide
sequence encoding the wild type amino acids, but with optimized codons was inserted between ATG191 and ATG356; 5, the region between codons 4
and 51 was deleted without altering the reading frame (for construct sequences, see Supplementary Figure 4). The ﬁreﬂy luciferase reporter activity
was normalized to Renilla luciferase expression also driven by a CMV promoter. (B)5 0 truncated sequence of the PTPRJ leader containing ATG191
was fused to the ﬁreﬂy luciferase (ATG356 was modied to CAT). In the region between ATG191 and ﬁreﬂy luciferase (from top to bottom): 1, the
nucleotide and the encoded amino acid sequence was left unchanged (wild type); the position of the arginine stretch is indicated (R). 2, the leader
sequence was 30 truncated after codon 26 (Arg), the reading frame was maintained; 3, the amino acid sequence of the region was altered by frame-
shifts at codons 4 and 13. 4, the amino acid sequence of the region was altered by frame-shifts at codons 4 and 27 (for construct sequences, see
Supplementary Figure 5). (C) Size of ﬁreﬂy luciferase products synthesized after transfection of HE293 cells with (191–356)Luc(pcDNA3) construct
[construct 1, in (A)]. The sizes of the products in total cell lysates (TCL) before and after immunoprecipitation (IP) were compared to the size of
control luciferase coded by pGL2 (Promega). (D) Reporter mRNA levels in HEK 293 cells transfected with ﬁreﬂy luciferase fusion constructs (vector
pcDNA3.1) with PTPRJ wild type or frame-shifted leader sequence as shown in (A). Total RNA isolated after transfection was loaded in two lanes
(amount of RNA diﬀered by factor of two), separated, blotted and hybridized with a DIG-labelled ﬁreﬂy luciferase DNA probe. To normalize, a
Renilla luciferase expression construct (CMV promoter) was cotransfected, the blot was stripped and reprobed with a DIG-labelled Renilla DNA
fragment (see Materials and Methods section).
4450 Nucleic Acids Research, 2008, Vol. 36, No. 13regulation we checked the expression of some of our
reporter constructs in several cell lines, and at diﬀerent
cell densities. As shown in Figure 8, luciferase expression
in the diﬀerent cell types was rather diﬀerent, with low
expression in HT29 cells, intermediate expression in
HeLa cells, and high expression in HEK293 and
HCT116 cells. It should be emphasized that the increased
expression in some cell lines cannot be explained by diﬀer-
ential promoter activity as the reporter ﬁreﬂy luciferase
and the control Renilla luciferase in these experiments
are expressed under the same CMV promoter. However,
the ratios of expression from wild type and mutated repor-
ter constructs were not altered signiﬁcantly. Therefore,
while our data suggest diﬀerences in eﬃciency of initiation
of translation at AUG191 in the diﬀerent cell lines, the
translation attenuation by the sequence encoded between
AUG191 and AUG356 can be observed in all of them,
indicating the generality of this mechanism for down-reg-
ulation. Since PTPRJ expression is elevated in some cell
lines at high culture densities, we also explored the possi-
bility that changes in translation eﬃciency would contri-
bute to this phenomenon. These experiments revealed
that, while reporter activity was clearly increased in cell
cultures at high density, the attenuation of translation
from AUG191 is still apparent in dense cells
(Supplementary Figure 7). This ﬁnding indicates that
upregulation of PTPRJ expression in dense cells is not
caused by a release from attenuated translation.
DISCUSSION
PTPRJ mRNA translation startsmainly atAUG191
The GC-rich 50 region of the PTPRJ mRNA is highly
conserved among mammals. We were particularly
attracted by the observation that a tandem arrangement
of in-frame AUGs present in the leader sequence in the
ﬁrst exon is highly conserved between the human and the
mouse (Figure 1). Therefore, we explored the putative
regulatory importance of this arrangement. It should be
noted that many of the 50UTRs of the human PTPs con-
tain uORFs with yet unexplored relevance for expression
regulation. However none of them contains a similar
tandem AUG arrangement. Only in case of hCD45/
PTPRC an in-frame upstream AUG was detected, which
was, however, only two codons apart from the proposed
translation start site (for details, see Supplementary
Tables 1 and 2). Nevertheless, the tandem AUG arrange-
ment is unlikely to be unique to PTPRJ. A recent search
of available cDNA human and mouse sequences has
revealed that some of the conserved AUG codons in the
50 leader are not followed by stop codons and are in the
same reading frame as the main protein (3). The relevance
of such tandem arrangements has, however, to the best of
our knowledge not yet been studied.
Our experiments showed that AUG191 is the preferred
starting codon in the context of the endogenous promoter.
Still, apparently not all ribosomes seem to recognize
it (leaky scanning). The least active starting codon is
AUG14 presumably due to its proximity to the m
7G cap
and its unfavorable context (Table 1).
AUG191 will direct the synthesis of the same PTPRJ
mature protein of 1302 amino acids, but the N-end of
(Pro-) PTPRJ is supposed to be 55 amino acids longer
than the previously predicted precursor. This has appar-
ently no eﬀect on the functioning of the PTPRJ as
our results showed that the N-end extended protein is
glycosylated in the same way as the PTPRJ, which starts
directly with a signal peptide of 35 amino acids
(Figure 2B). Apparently, in each form the N-end region
of the protein is recognized by the signal recognition par-
ticle, cleaved by the signal peptide peptidases, the mature
protein being correctly glycosylated. Moreover, our results
indicate that the exact sequence of the additional 55 amino
acids is not a precondition for the protein maturation.
These results are in agreement with previous data showing
that the signal peptide retains its function when situated
downstream of the N-end of a protein (26).
The region between AUG191 and AUG356 isdifficult
totranslate
The analysis of the activity of the various reporter con-
structs indicated that the region downstream of AUG191 is
not eﬃciently translated, and translation of the 55 codons
at the N-end seems to be a rate-limiting step in the overall
protein expression. The alteration of 47 codons of the
same region by shifting and restoring the reading frame
resulted in marked increase in reporter activity. Impor-
tantly, this eﬀect on translation does not depend on the
promoter. Essentially the same results were obtained when
transcription was driven not by the endogenous PTPRJ
promoter, but by the strong cytomegalovirus promoter.
Only a modest increase in the expression was observed
when the wild-type sequence was replaced by a synthetic
fragment encoding the same amino acids, but with ‘opti-
mized’ codons. This suggests that the presence of rare
codons is not the primary reason for the observed transla-
tion inhibition. Moreover, our results showed that the
attenuation of translation depends more speciﬁcally on
13 amino acids at the N-end of the protein. Based on
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Nucleic Acids Research, 2008, Vol. 36, No. 13 4451these ﬁndings we propose that the translation inhibition is
due to the sequence of the nascent peptide. Examples of
translation regulation through interaction between the
nascent peptides and the ribosome are well known for
prokaryotes (27). The translation inhibition exerted in
cis- by some uORF in eukaryotes depends also on their
amino-acid sequence. In these cases, according to the
accepted model, the nascent uORF encoded peptide inter-
acts with the ribosome and prevents its release at the
uORF termination codon (5,7). In the mRNA of the b2
adrenergic receptor, the uORF encodes a peptide which
supposedly interacts with the messenger, and thereby inhi-
bits translation (28). For mammalian genes, to the best of
our knowledge, observations of regulatory peptides
encoded by domains within the main coding sequence
have not yet been reported. In Arabidopsis, however,
a stretch of 11–13 amino-acid residues, located 80 residues
from the N-terminus of the cystathionine gamma-
synthetase CGS1 gene, causes a nascent peptide-mediated
translation elongation arrest most likely at the step of
ribosome translocation (29).
We do not know yet the exact mechanism by which the
nascent stretch of 13 amino acids encoded by the PTPRJ
50 leader causes translational attenuation. Several mechan-
isms are feasible. One is the interaction of the nascent
residues with the ribosome, interfering either with some
of the elongation steps (the peptidyl transfer and the trans-
location are candidates) or with the exit of the polypeptide
from the ribosome through the exit tunnel (30–32).
Another possibility is an elongation arrest by interaction
of the nascent chain with mRNA as proposed for the
peptide synthesized by the uORF of the b2 adrenergic
receptor mRNA. It is relevant to note that the only gen-
eral feature of the nascent peptides interacting with the
ribosome is that they are not acidic, some being highly
basic (27). The amino acids which are involved in transla-
tion attenuation of PTPRJ comprise a conserved stretch
of 13 residues (RRTGWRRRRRRRR) containing 10 Arg
residues. It is tempting to speculate that the properties of
this stretch of amino acids are important for ineﬃcient
translation by binding to the ribosome or the mRNA.
The inhibiting peptide of the b2 adrenergic receptor
mRNA has revealed the critical role of three consecutive
arginine residues for inhibition (28). In Escherichia coli the
translation of regions particularly rich in arginine is
impaired (33). Still another reason for impeded translation
of the primary ORF could be the existence of signiﬁcant
ribosome frameshifting, which might possibly take place
along sequences between AUG191 and AUG356 (for exam-
ples of +1 and  1 frameshifting in eukaryotes see http://
recode.genetics.utah.edu/).
Attenuating the translation of PTPRJ may be impor-
tant to maintain the cellular levels of a critical regulatory
and possibly harmful protein low. Potentially, it could
also present the basis for regulation, assuming that the
translation constraint can be overcome in certain diﬀeren-
tiation states or under certain conditions of cell stimula-
tion. While our experiments showed a marked cell speciﬁc
degree of expression of the reporter constructs (Figure 8),
they indicated that attenuation of translation via the
described mechanism operates in a similar manner in all
analyzed cell lines. Also, we did not yet observe diﬀerences
in the extent of translational repression at diﬀerent cell
densities, or in cells stimulated with a variety of growth
factors or cytokines (Supplementary Figure 7, and R.
Godfrey, unpublished data). Further work is required to
address the possibility that expression can be modulated
by a mechanism involving the tandem AUGs and the
translational repression by the speciﬁed stretch of amino
acids. Alternatively, the described inhibition of translation
may be constitutive and merely serve to achieve low levels
of PTPRJ protein, thereby permitting a more eﬀective
expression control by other mechanisms, such as tran-
scriptional activation.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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